Polymorphisms G691S/S904S of RET as genetic modifiers of MEN 2A.Mercedes Robledo, José M. Rojas, Laura Gil et al.|PubMed|2003Cited by 140
Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphomaFabian Frontzek, Georg Lenz, Annette M. Staiger et al.|Nature Communications|2021Cited by 49
Thyroid paraganglioma. Report of 3 cases and description of an immunohistochemical profile useful in the differential diagnosis with medullary thyroid carcinoma, based on complementary DNA array resultsEsmeralda Castelblanco, Xavier Matías‐Guiu, Sónia Gatius et al.|Human Pathology|2011Cited by 28
Genetic and phenotypic characterisation of <scp>HIV</scp>‐associated aggressive B‐cell <scp>non‐Hodgkin</scp> lymphomas, which do not occur specifically in this population: diagnostic and prognostic implicationsMaria João Baptista, José‐Tomás Navarro, Gustavo Tapia et al.|Histopathology|2022Cited by 13
The role of miR-150-5p/E2F3/survivin axis in the pathogenesis of plasmablastic lymphoma and its therapeutic potentialMiriam Verdú-Bou, José‐Tomás Navarro, Maria João Baptista et al.|Blood Advances|2025Cited by 5